BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17945300)

  • 1. Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder.
    Neel KF; Soliman S; Salem M; Seida M; Al-Hazmi H; Khatab A
    J Urol; 2007 Dec; 178(6):2593-7; discussion 2597-8. PubMed ID: 17945300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele.
    Kajbafzadeh AM; Moosavi S; Tajik P; Arshadi H; Payabvash S; Salmasi AH; Akbari HR; Nejat F
    Urology; 2006 Nov; 68(5):1091-6; discussion 1096-7. PubMed ID: 17113899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.
    Neel KF; Salem M; Soliman S
    J Pediatr Urol; 2008 Apr; 4(2):124-6. PubMed ID: 18631907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele].
    Lusuardi L; Nader A; Koen M; Schrey A; Schindler M; Riccabona M
    Aktuelle Urol; 2004 Feb; 35(1):49-53. PubMed ID: 14997415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods.
    Safari S; Jamali S; Habibollahi P; Arshadi H; Nejat F; Kajbafzadeh AM
    Urology; 2010 Jul; 76(1):225-30. PubMed ID: 20110117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
    Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding.
    Petronijevic V; Lazovic M; Vlajkovic M; Slavkovic A; Golubovic E; Miljkovic P
    J Urol; 2007 Dec; 178(6):2599-602; discussion 2602-3. PubMed ID: 17945299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
    Giannantoni A; Di Stasi SM; Nardicchi V; Zucchi A; Macchioni L; Bini V; Goracci G; Porena M
    J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
    Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
    Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
    Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
    BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
    Kuo HC
    J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total endoscopic and anal irrigation management approach to noncompliant neuropathic bladder in children: a good alternative.
    Neel KF
    J Urol; 2010 Jul; 184(1):315-8. PubMed ID: 20488484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
    Horst M; Weber DM; Bodmer C; Gobet R
    Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
    Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M
    Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.
    Tsai SJ; Ying TH; Huang YH; Cheng JW; Bih LI; Lew HL
    Arch Phys Med Rehabil; 2009 May; 90(5):832-6. PubMed ID: 19406304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder.
    Khan MK; VanderBrink BA; DeFoor WR; Minevich E; Jackson E; Noh P; Reddy PP
    J Pediatr Urol; 2016 Apr; 12(2):104.e1-6. PubMed ID: 26778185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.